The Contemporaneous and Impending Developments for Combatting COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative viral agent for the COVID-19 infection has rapidly spread worldwide. The SARS-CoV-2 infection spread around the globe (~198 countries) and true statistics of this pandemic are difficult to estimate due to significantly limited healthcare capability around the world. For the alleviation, the effects of the SARS CoV-2 virus on public health and the economy, a vaccine is urgently needed. Currently, more than 10 vaccine candidates have reached the final phase of the clinical trial. The global scale-up of vaccine trials requires a massive testing and immune monitoring effort that is unprecedented in modern science. While there are many vaccination strategies, the common theme is that these must elicit sustained immunity that is predicated on the production of neutralizing or blocking antibodies that recognize exposed protein epitopes. Today this process remains entirely laboratory bound, is costly, and in the availability of common assay for assessing immunity across multiple vaccines hence an urgent preparedness needed to overcome forthcoming challenges.
References
-
United States Coronavirus: 6,718,969 Cases and 198, 643 Deaths-Worldometer.
-
Morens DM, Fauci AS (2020) Emerging Pandemic Diseases How We Got to COVID-19. Cell 182(5): 1077– 1092
-
Pascarella G, Alessandro Strumia, Chiara Piliego, Federica Bruno, Romualdo Del Buono, et al. (2020) COVID-19 diagnosis and management a comprehensive review J Intern Med 288(2): 192–206.
-
Singh NK, Partha Ray, Aaron F Carlin, Celestine Magallanes, Sydney C Morgan, et al. (2020) Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer.
-
Budd J, Benjamin S Miller, Erin M Manning, Vasileios Lampos, Mengdie Zhuang, et al. (2020) Digital technologies in the public-health response to COVID-19 Nat Med 26(8): 1183-1192.
-
Jeyanathan M, Sam Afkhami, Erin M Manning, Vasileios Lampos, Mengdie Zhuang, et al. (2020) Immunological considerations for COVID-19 vaccine strategies Nat Rev Immunol 20(10): 615-632
-
Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586: 516-527.
-
Rogers TF, Fangzhu Zhao, Deli Huang, Nathan Beutler, Alison Burns, et al. (2020) Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369(6506): 956-963.
-
Centers for Disease Control and Prevention CDC (2019) Information for Laboratories about Coronavirus (COVID-19).
-
Wang C, Wentao Li, Dubravka Drabek, Nisreen M A Okba, Rien van Haperen, et al. (2020) A human monoclonal antibody blocking SARS-CoV-2 infection Nat Commun11(1): 2251
-
Kubina R, Dziedzic A (2020) Molecular and Serological Tests for COVID-19 A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics 10(6): 434.
- Epidemiological and Clinical Aspects of Intestinal Parasitoses Among Students in the City of Bocaranga, Central African Republic
- Artificial Intelligence Empowers Global Infectious Disease Prevention and Control: Opportunities and Challenges
- Factors that Affect the Incidence of Babesia and Blood Donor Testing in Select States: A Regression Analysis
- Neuro-TB: The Battle between Tuberculosis and the Nervous System
- The Biological and Health Implications of Cat Fleas (Ctenocephalides felis): Assessing Zoonotic Risks and Hygiene Strategies
- Biostatistical Analysis of Medicinal Plants for Treating Schizophrenia